CHANDAN

Chandan Healthcare Share Price

 

 

Start SIP in CHANDAN

Start SIP

Performance

  • Low
  • ₹314
  • High
  • ₹333
  • 52 Week Low
  • ₹140
  • 52 Week High
  • ₹355
  • Open Price₹330
  • Previous Close₹326
  • Volume66,400

Investment Returns

  • Over 1 Month + 39.2%
  • Over 3 Month + 33.83%
  • Over 6 Month + 76.42%
  • Over 1 Year + 107.48%

Smart Investing Starts Here Start SIP with Chandan Healthcare for Steady Growth!

Invest Now

Chandan Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 36.4
  • PEG Ratio
  • -
  • Market Cap Cr
  • 807
  • P/B Ratio
  • 13.7
  • Average True Range
  • 17.88
  • EPS
  • 9.07
  • Dividend Yield
  • 0
  • MACD Signal
  • 21.3
  • RSI
  • 62.14
  • MFI
  • 67.5

Chandan Healthcare Financials

Chandan Healthcare Technicals

EMA & SMA

Current Price
₹329.90
+ 3.8 (1.17%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 14
  • 20 Day
  • ₹311.52
  • 50 Day
  • ₹279.66
  • 100 Day
  • ₹252.21
  • 200 Day
  • -

Resistance and Support

325.75 Pivot Speed
  • R3 355.80
  • R2 344.40
  • R1 337.15
  • S1 318.50
  • S2 307.10
  • S3 299.85

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Chandan Diagnostics is a leading healthcare provider with 50+ centers and 500 collection points across Uttar Pradesh, Uttarakhand, and Rajasthan. Offering 3,500+ tests across multiple specialties, it ensures high-quality diagnostics with ISO and NABL-certified labs, cutting-edge automation, and seamless digital access.

Chandan Healthcare Ltd has an operating revenue of Rs. 663.16 Cr. on a trailing 12-month basis. An annual revenue growth of 30% is outstanding, Pre-tax margin of 14% is healthy, ROE of 18% is exceptional. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 23% and 50% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 16% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 54 which is a POOR score indicating inconsistency in earnings, a RS Rating of 94 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 2 indicates it belongs to a strong industry group of Medical-Outpnt/Hm Care and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Chandan Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-10-10 To consider Fund Raising
2025-05-27 Audited Results

Chandan Healthcare F&O

Chandan Healthcare Shareholding Pattern

49.43%
3.86%
33%
13.71%

About Chandan Healthcare

  • NSE Symbol
  • CHANDAN
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Amar Singh
  • ISIN
  • INE0B2N01016

Similar Stocks to Chandan Healthcare

Chandan Healthcare FAQs

Chandan Healthcare share price is ₹329 As on 08 November, 2025 | 05:25

The Market Cap of Chandan Healthcare is ₹806.7 Cr As on 08 November, 2025 | 05:25

The P/E ratio of Chandan Healthcare is 36.4 As on 08 November, 2025 | 05:25

The PB ratio of Chandan Healthcare is 13.7 As on 08 November, 2025 | 05:25

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23